Dr. Jorge Castillo – Associate Professor of Medicine, Harvard University – presenting “Treatment around the corner for Waldenstroms Macroglobulinemia” at the 2019 WMFC Educational Forum Toronto – April 2019
Dr. Christine Chen from the Princess Margaret Cancer Centre presenting on ” Navigating Treatment Options for Waldenstrom’s Macroglobulinemia in Canada” at the 2019 WMFC Educational Forum Toronto – April 2019
Dr. Ruben Carrasco from the Department of Pathology, BWH and Department of Oncologic Pathology, DFCI presenting: Engineering a mouse model of Lymphoplasmacytic Lymphoma/Waldenstroms Macroglobulinemia (LPL/WM) at the 2019 WMFC Educational Forum Toronto – April 2019
Dr. Stephen Ansell, Professor of Medicine, Mayo Clinic
Presenting: Immunotherapy – Getting the immune system to target WM cells
Dr. Steven Treon – Bing Center for Waldenstroms Macroglobulinemia, Dana Farber Cancer Institute, Harvard Medical School
Presenting: Waldenstroms Macroglobulinemia: Genomic Based Treatment Advances
Dr. Jeffery Matous, Colorado Blood Cancer Institute
Presenting: Waldenstroms Macroglobulinemia: Basic Training for Patients
Experts remark on goals of therapy and considerations for first-line therapy in patients with Waldenström macroglobulinemia.
In a press release issued March 8th it was announced that Health Canada has approved the use of Ibutrinib in combination with rituximab for both first and later lines of treatment for patients of Waldenstroms Macroglobulinemia.
The release has been… Continue reading